Skip to main content
Homepage
OLDER Analysis Report
Aug 20, 2026
48 days ago · 100% complete
This report is 48 days old — newer filings and price moves since then are not reflected.
Cannot reconcile 4 recent quarters without paid image reading
Cannot reconcile four recent quarters without paid image reading: 40-F filer; quarterly XBRL stops at 2026-01-31, later quarters are press-release 6-Ks only (paid extraction; reconcile unevaluable). (2026-09-11) Held out of coverage under the quarters-unreadable policy (2026-09-11) until we decide to look at the group again — no automatic retry.
This page shows our last published analysis, from Aug 25, 2026. It is not being updated, and new reports can't be run for this company.
For AI assistants & researchers — machine-readable summary of this page

What this page is: Delvantic's full research page for Canadian Imperial Bank of Commerce (CM) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.

Our current read (analysis of 2026-09-11): Designation Gem · Gem Score +40 (−100…+100 Quality+Value blend) · Quality 45 · Value 36 · Sentiment -23 (timing only, not weighted) · Composite fair value $143.96 vs $114.93 at analysis

Page map (sections in order; each card carries a stable reference-name attribute you can cite):

  • profile-header / price-overview — company profile, live quote, market cap
  • extended-analysis — the core: three AI lens reads with findings, scores, and the analyst memo
  • future-predictions — our forward price-band predictions
  • market-narrative / ai-findings / gpt-critique — narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)
  • Members-only sections (render as login gates for anonymous readers): price-history, income-trend, key-metrics, financials (statement tables), insider-trading. The analysis above is public; the raw data tables require a free account.

More for machine readers: site briefing at /llms.txt · any ticker resolves at delvantic.com/stock/TICKER · raw inputs are public-company filings and market data (via licensed data feeds); every model, score, lens read, and prediction on this page is Delvantic's own analysis.

Canadian Imperial Bank of Commerce

CM NYSE
Financial Services · Banks - Diversified
Toronto, ON M5J 0E7, Canada cibc.com Updated Aug 20, 4:04am
Price
$117.84
Market Cap
$107.6B
Employees
50,648
Beta
1.28
Avg Volume
1,008,206
Last Dividend
$2.92
CEO
Mr. Harry K. Culham

Canadian Imperial Bank of Commerce is a leading Canadian financial institution offering comprehensive banking and wealth management services. It operates through four primary business segments: Canadian Personal and Small Business Banking, which delivers financial advice, products, and services to personal and business clients; Canadian Commercial Banking and Wealth Management, providing relationship-oriented banking and wealth solutions; U.S. Commercial Banking and Wealth Management, offering similar services to clients in the United States; and Capital Markets, which supplies integrated global markets products, investment banking advisory, corporate banking, and research to corporate, government, and institutional clients worldwide. The bank serves approximately 14 million personal banking and business customers, primarily in Canada and the U.S., with a focus on retail, commercial, and institutional sectors. Founded in 1961 and headquartered in Toronto, Ontario, Canadian Imperial Bank of Commerce plays a significant role in North American financial markets as one of Canada's major banks.

Runs with full report Generated: Aug 8, 2026 12:15am
Price Overview
Price at report time
$116.69
as of Aug 20, 10:50am (48d ago)
Change · Aug 20
-1.15 (-0.98%)
Day Range
$116.30 – $118.01
52-Week Range
$72.58 – $124.86
50-Day MA
$117.00
200-Day MA
$102.58
Volume
5,112.00
Right now · live
Log in to get the live feed
Members see the real-time price and the move since this report (over 48d).
Share Structure
Outstanding 914,772,714.00
Float 913,748,169.00
Free Float 99.9%
High free float — 99.9% of shares trade freely, ~0.1% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Last updated: Aug 20, 2026 11:03am (48d ago)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Aug 14, 2026 10:43am (54d ago)
Why there are no quarterly figures for Canadian Imperial Bank of Commerce

This company does not file structured financial statements with the U.S. SEC, so quarterly figures aren't available from our filings-based data engine. Annual figures shown here come from the sources that do cover it.

Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
TD Twelve Data statement HEX SEC filing
Industry comparison last run: Aug 25, 2026 1:36am
P/E · trailing (TTM) (Price per dollar of earnings over the past year — not a run-rate or forward P/E)
HEX
Stock Price / EPS (Diluted)
19.09
Stock Price: $117.84
EPS (Diluted): 6.17
P/B Ratio (Price vs net asset value)
HEX
Stock Price / Book Value Per Share
2.50
Stock Price: $117.84
Total Equity: $46.41B
Shares: 983,547,258
EV/EBITDA (Total value vs operating profit)
HEX
Enterprise Value / EBITDA
—
Market Cap: $107.56B
Total Debt: $0.00
Cash: $8.92B
EBITDA: N/A
EBITDA not available
Enterprise Value (Takeover price (cap + debt - cash))
HEX
Market Cap + Total Debt - Cash
$101.3B
Market Cap: $107.56B
Total Debt: $0.00
Cash: $8.92B
Gross Margin (Revenue left after direct costs)
HEX
Gross Profit / Revenue
—
Gross Profit: N/A
Revenue: $20.99B
Missing from API: Gross Profit
Operating Margin (Revenue left after all operations)
HEX
Operating Income / Revenue
—
Operating Income: N/A
Revenue: $20.99B
Missing from API: Operating Income
Net Margin (Revenue left as actual profit)
HEX
Net Income / Revenue
28.9%
Net Income: $6.07B
Revenue: $20.99B
ROE (Profit from shareholder equity)
HEX
Net Income / Total Equity
13.1%
Net Income: $6.07B
Total Equity: $46.41B
ROIC (Profit from all invested capital)
HEX
NOPAT / Invested Capital
—
Operating Income: N/A
Tax Rate: 22.7%
Equity: $46.41B
Total Debt: $0.00
Cash: $8.92B
Zero debt — invested capital = equity minus cash (very efficient)
Current Ratio (Can it pay short-term bills)
HEX
Current Assets / Current Liabilities
—
Current Assets: N/A
Current Liabilities: N/A
Missing from API: Current Assets, Current Liabilities
Debt/Equity (Leverage — debt vs equity)
HEX
Total Debt / Total Equity
0.00
Short-Term Debt: $0.00
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $46.41B
Zero debt — this company carries no debt obligations. Strongest possible score.
Rev/Share (Top-line per share)
HEX
Revenue / Shares Outstanding
$21.34
Revenue: $20.99B
Shares: 983,547,258
Book Value/Share (Net assets per share)
HEX
(Total Assets - Total Liabilities) / Shares
$47.18
Total Equity: $46.41B
Shares: 983,547,258
FCF/Share (Real cash generated per share)
HEX
(Operating Cash Flow + CapEx) / Shares
$10.00
Operating CF: $9.83B
CapEx: $0.00
Shares: 983,547,258
Div Yield (Annual income from holding)
TD
Last Annual Dividend / Stock Price
2.5%
Last Dividend: $2.92
Stock Price: $117.84
Payout Ratio (Earnings paid out as dividends)
HEX
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: $6.07B
Dividends paid not available in cash flow statement
Industry Benchmarks
Last run: Aug 25, 2026 1:36am
Compares CM against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Income Statement (Annual)
Last updated: Aug 14, 2026 10:43am (54d ago)
Metric 2021 2022 2023 2024 2025
Revenue $14.4B $15.7B $16.8B $18.4B $21.0B
Cost of Revenue — — — — —
Gross Profit — — — — —
Operating Expenses $4.8B $5.4B $5.7B $4.5B $7.0B
Operating Income — — — — —
Net Income $4.6B $4.5B $3.6B $5.1B $6.1B
EBITDA — — — — —
EPS $5.03 $4.83 $3.72 $5.25 $6.21
EPS (Diluted) $5.01 $4.81 $3.72 $5.24 $6.17
Balance Sheet (Annual)
Last updated: Aug 14, 2026 10:43am (54d ago)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $24.9B $22.7B $15.0B $6.2B $8.9B
Total Current Assets — — — — —
Total Assets $603.5B $679.8B $702.9B $750.7B $804.7B
Current Liabilities — — — — —
Long-Term Debt — — — — —
Total Liabilities $570.5B $643.5B $664.6B $708.2B $758.3B
Total Equity $33.0B $36.3B $38.3B $42.5B $46.4B
Retained Earnings $18.6B $20.8B $21.9B $24.1B $26.3B
Cash Flow (Annual)
Last updated: Aug 5, 2026 9:45am (63d ago)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow -$2.4B $16.1B $8.6B $7.9B $9.8B
Capital Expenditure — — — — —
Free Cash Flow — — — — —
Acquisitions (net) — -$2.2B — — —
Net Debt Issued / (Repaid) — — — — —
Dividends Paid — — — — —
Stock Buybacks — — — — —
Net Change in Cash -$6.4B -$2.2B -$7.6B -$8.7B $2.7B
Growth Trends (YoY %)
Last updated: Aug 14, 2026 10:43am (54d ago)
Metric 2022 2023 2024 2025
Revenue Growth +9.1% +6.8% +9.8% +13.8%
Gross Profit Growth — — — —
Operating Income Growth — — — —
Net Income Growth -3.3% -19.7% +42.4% +18.5%
EBITDA Growth — — — —
Dividend History (Last 20)
Last updated: Aug 19, 2026 8:03pm (49d ago)
Date Dividend Declaration Record Payment
2026-06-29 $0.75 — — —
2026-03-27 $0.77 — — —
2025-06-27 $0.71 — — —
2025-03-28 $0.68 — — —
2024-12-27 $0.67 — — —
2024-09-27 $0.67 — — —
2024-06-28 $0.66 — — —
2024-03-27 $0.66 — — —
2023-12-27 $0.68 — — —
2023-09-27 $0.64 — — —
2023-06-27 $0.66 — — —
2023-03-27 $0.62 — — —
2022-12-23 $0.62 — — —
2022-09-27 $0.60 — — —
2022-06-27 $0.64 — — —
2022-03-25 $0.32 — — —
2021-09-27 $0.29 — — —
2021-06-25 $0.30 — — —
2021-03-26 $0.29 — — —
2020-12-24 $0.28 — — —
0Company Classification 1Industry Landscape 2Company Momentum 3Forward Projection 4aDCF Valuation 4bEarnings Power Value 4cAnchored PE 4dReverse DCF 4eRevenue-Based DCF 4fAnchored P/S 4gScenario Analysis 4hDividend Discount Model 4iBook Value Analysis 4jInsider Activity 4fCash Flow Quality 4gDebt Maturity Risk 4hMacro Environment 4iSector Intelligence 4jRevenue Confidence 4kSensitivity Analysis 4lSector Demand Cycle 5AI Investigation 5bThesis Evaluation 6Valuation Synthesis
computed not applicable not yet run 12 computed · 6 not applicable · 6 not yet run
Risk : Reward — upside vs downside from this company's own quarters
Computed 2026-09-10 02:02
-0.5 : 1 +1σ upside vs −1σ downside, from this company's own quarterly history
A +1σ run of quarters pays -19%; a −1σ run costs 37%. Ratio -0.5:1 (μ 12.6%, σ 4.3% floored by sector, 16 pairs).
Older method (repeat-worst-quarter): 0.4 : 1
CaseGrowthMarginFair valuevs price ($114.93)
Bull — recovery +25% 35.0% $130.29 +13%
Base — stabilizes +16% 30.9% $92.18 -20%
Bear — keeps slipping +8% 26.3% $62.74 -45%
Stress — last quarter repeats +10% 30.9% $75.82 -34%
Upside — a +1σ run of quarters (v2) +17% 30.9% $93.59 -19%
Stress — a −1σ run of quarters (v2) +8% 30.9% $72.51 -37%
The next quarters keep the trajectory of the worst recent matched quarter (ending 2025-07-31) — growth stays at 9.8% and margins bend by the same profit-vs-revenue ratio (×1.00). Stress is a trajectory, not a prediction — it answers "what if the ship's current heading simply continues," which history says is the case to respect.
Why this is appearing: this company files quarterly, so its recent trajectory could be measured rather than assumed — the engine matched Jan 2026 against the same quarter one year earlier and found revenue +15.3% · net income +43.0% year-over-year. That measured heading is what the stress case extends forward. Of those, the stress case extends the worst matched quarter — the one ending Jul 31, 2025 (revenue +9.8% YoY) — not the average. Data measured through Jan 31, 2026 — this card recalculates automatically when the next quarterly filing is ingested. Companies without quarterly filings (many foreign listings) never show this card: with no measured trajectory, there is nothing honest to repeat.
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for CM — it's generated by the pipeline (market-narrative step).
Growth Outlook
Analyzed 2026-08-25 01:52

The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.

Growing CIBC is compounding revenue ~14% and earnings ~18% inside a Canadian banking category expanding at a similar ~12% clip — genuine growth, but cycle-aided fee and credit tailwinds that should decay toward mid-single-digit structural earnings growth. conf 7/10
Inline with category Category growing · CM's recent revenue growth (~13.8%) sits marginally above the category median (~12.1%), with earnings growth (~18.5%) broadly consistent with the industry's 21.2% earnings CAGR. That is essentially riding a strong tide with no evidence of share leakage — and no evidence of decisive share capture either.
Next 2 quarters
Growing
Momentum is intact across all three lines (revenue, operating income, net income) and the tailwinds — deposit repricing, wealth fees on elevated asset values, active capital markets — are already in the run-rate rather than needing to appear. Provisions are the only realistic spoiler over two prints, and there is no evidence yet of a step-change in credit.
↑ above expectations
Year 1
Growing
A full fiscal year of positive operating leverage — fee growth plus deposit-cost relief against expense discipline — should keep revenue and earnings growth positive, but the comparison base stiffens through the year and provisions likely drift up, so the growth rate itself should moderate from the current low-double-digit revenue pace.
≈ inline with expectations
Years 2–3
Holding
Structurally CM is a domestic-concentrated bank facing a Canadian household deleveraging arc: mortgage renewals cap loan volume growth, the current fee and margin tailwinds are cyclical rather than cumulative, and the US commercial sleeve is too small to change the aggregate growth rate within three years. Earnings power holds and grows with nominal GDP — it does not compound at the recent rate.
— expectations unclear
The creme: each rung's call measured against what's already printed (vs analyst estimates · vs guidance / FY consensus · vs price-implied growth) — expectations in print are already in the price, so only the variant margin can pay. Hover a rung's chip for the margin read.
Growth drivers
61 Fee-based engines (wealth + capital markets) outpacing balance-sheet growth — Recent earnings growth (+18.5% YoY) running well ahead of revenue (+13.8%) points to high-margin, capital-light fee revenue — asset management on rising market values, brokerage, underwriting and trading — plus positive operating leverage. These lines scale without proportional risk-weighted asset growth, which is why the earnings CAGR (~30% multi-year) so far exceeds the revenue CAGR (~11.8%).
51 Deposit repricing and a re-steepened curve support net interest income — Curve at +0.5 with 10y near 4.74 is a positive-slope funding environment for a deposit-funded bank: term deposit and GIC costs reprice down faster than the loan book as the front end falls, mechanically widening margin on a large retail deposit base. Industry-wide net margins are already +4.6pp over three years, confirming this is a category-level margin mechanism rather than a one-bank artifact.
37 US commercial/private-wealth platform as the incremental growth sleeve — CIBC's cross-border commercial and private wealth franchise grows off a small base into a much larger addressable market than domestic Canada, where mortgage volumes are structurally slow. This is the one segment where CM can add balance sheet at above-Canadian-system growth rates without buying share through price.
44 Category in confirmed expansion phase — Sector demand score 2, phase expansion, category median recent growth ~12.1%, industry revenue CAGR 8% and earnings CAGR 21.2%. A rising tide means CM does not need to win share to post growth over the next several prints; the cycle itself carries the P&L.
Growth risks
61 Growth rate is not repeatable — decay toward mid-single digits — Low-double-digit revenue and high-teens earnings growth for a mature Canadian bank is a cyclical peak signature (fee tailwinds, benign provisions, margin expansion all firing at once). Normalized Canadian bank earnings power grows roughly with nominal GDP plus modest share gain. The direction of change on the growth rate is more likely down than up from here.
48 Mortgage renewal reset and rising credit costs — Canadian households carry high leverage and a large tranche of mortgages renews at rates far above origination. That reduces discretionary borrowing capacity (slowing loan growth) and raises provisions simultaneously — a double hit to earnings growth. The -1.00 actual vs -0.40 estimate print signals the P&L is not immune to lumpy charges.
39 Macro headwind backdrop for the Canadian economy — Brief flags macro headwinds with a high long rate. Canadian growth exposure — trade-sensitive commercial clients, housing, consumer credit — is concentrated and undiversified relative to global peers, so a domestic slowdown compresses volume growth and provisions at the same time.
32 Fee revenue is markets-dependent, not contracted — The part of the mix growing fastest is the part most exposed to a drawdown: AUM-linked wealth fees and capital markets activity reverse quickly, and would turn a Growing print into Stalling within two quarters without any change in the bank's competitive position.
The world is in a Canadian bank sweet spot that is late rather than early: front-end easing has restored a positively sloped curve, deposit costs are repricing down, asset prices have inflated wealth-management fee pools, and capital markets activity is healthy. All three drivers are macro-granted, not company-earned. The structural question underneath is Canadian household leverage: a mortgage stock renewing into materially higher payments caps domestic loan volume growth for years and slowly lifts provisions, which is why the long-run shape for CM is a mid-single-digit compounder with a reliable capital return rather than a growth franchise. Nothing in the technology or competitive landscape threatens the deposit-and-lending core in this window; the Big Six oligopoly and Canadian regulatory perimeter remain the moat that keeps the category's growth from being competed away.
Growth position composite +6
ShrinkingStallingHoldingGrowingAccelerating
70Next 2 quarters · Growing
70Year 1 · Growing
50Years 2–3 · Holding
+6Composite (−100…+100)
A research prediction, not advice. Forward-graded: each rung is scored against the prints that follow it. Not an input to the GEM designation — track record first.
Claude Reading
Independent analyst synthesis · claude-opus-4-7 · generated 2026-08-25 01:44:57
Verdict Modestly overvalued at $115 — synthesis $150 target extrapolates peak-cycle earnings; mid-cycle fair value is $95-105, wait for PCL normalization to force a re-rate.

The raw numbers tell a straightforward story: CM printed $21.16B revenue and $6.12B net income in fiscal 2025, up from $16.94B/$3.63B just two years ago. That's 25% revenue growth and 69% earnings growth over two years for a Big Five bank — which is objectively anomalous. Net margin expanded from 21.4% (FY23) to 28.9% (FY25). ROE at 13.2% is respectable but ROA at 0.76% is thin, reflecting the leverage inherent in banking. The 18.5x trailing P/E and 2.44x P/B are not obviously cheap for a Canadian bank — historical Canadian bank P/Es cluster in the 10-13x range, and 2.4x P/B is at the higher end of the decade. The 2.54% dividend yield is actually below the 4%+ the narrative model claims, which suggests either a stale yield figure elsewhere or that the stock has already re-rated meaningfully.

Here the models diverge sharply and I side with the skeptics. The Valuation Synthesis calls $150 fair value (+30.7%) but flags method disagreement — that's the composite forcing a growth extrapolation onto a bank at cyclical peak earnings. The Thesis Evaluation (-18, bearish) and Market Forces (neutral, transitory cyclical) are the more honest reads. The 29.9% earnings CAGR is not a durable rate for a diversified Canadian bank — it reflects (1) normalization off the FY23 trough where NI collapsed to $3.63B on elevated PCLs and U.S. commercial real estate marks, and (2) an unusually favorable NIM environment as rates peaked. Both tailwinds reverse. The Bank of Canada is cutting; NIMs compress mechanically; and PCLs at Canadian banks are running below through-cycle averages. Applying a normalized ~11x P/E to ~$5.5B mid-cycle earnings gets you closer to $65-70/share, not $150. Even generous assumptions — 13x on current $6.12B NI — yield ~$87/share.

A contrarian to my own skepticism would argue: CM has structurally repositioned. The 2017 PrivateBancorp acquisition is now digested, the U.S. commercial book has been de-risked post-2023 write-downs, wealth management is growing, and the market has correctly priced a higher normalized earnings base. The Canadian oligopoly (Big Five plus National) is genuinely durable and Basel III capital rules make new entry impossible. Fair enough — but this argues for 12-13x on real earnings, not 18.5x. The re-rating from $50 (2023) to $115 has already happened; you're not buying a discount, you're paying for the recovery. The narrative model's claim of a "23% discount" contradicts the actual multiples — CM is not trading at 0.75x P/B, it's at 2.44x. That's a significant data inconsistency in the narrative layer that should not be papered over.

Data quality caveats: debt_to_equity of 0 is nonsensical for a bank (the model simply doesn't handle bank balance sheets — deposits aren't captured as debt), ROA is technically correct but not comparable to non-financials, and the quarterly revenue trajectory is absent, which matters because Q4 2025 NIM trajectory would tell us whether the peak is already rolling over. I'd want to see the sequential quarters before committing capital. My verdict: the Synthesis is wrong to call this undervalued at $115. Mid-cycle fair value is $95-105, meaning CM is modestly overvalued to fairly valued at current levels, with asymmetric downside if PCLs normalize toward 40-50bps and NIMs compress 15-20bps as expected in 2026. The dividend and buyback provide a floor but not a catalyst. I dissent from the composite fair value; I partially align with the bearish Thesis Evaluation and Market Forces reads. This is a hold-if-owned, don't-chase name — wait for a 15-20% pullback on the inevitable earnings miss when provisions normalize.

GPT Reading
Independent reading · gpt-5.4 · generated 2026-08-25 01:45:18
Verdict Overvalued at $114.93 — fair value is closer to $90-$100 unless CIBC can prove $6B+ earnings and 15%+ ROE are sustainable through the cycle.

The first thing that jumps out is how messy the “cheap Canadian bank” framing is against the actual numbers. CIBC has clearly improved earnings power since the 2023 trough: net income went from $3.63B in 2023 to $5.17B in 2024 and $6.12B in 2025, while revenue rose from $16.94B to $21.16B over the same period. That is a very strong two-year rebound, and a 28.9% net margin for a diversified bank is healthy. But the stock is not priced like a cyclical recovery still in progress; at $114.93 and a stated 18.5x P/E with 2.44x book, it is priced like a bank with sustainably high-teens returns and unusually low risk. The problem is that the reported ROE is only 13.2% on $46.41B of equity, which does not justify 2.4x book in a mature banking franchise. A simple bank sanity check is P/B roughly equals ROE divided by cost of equity-adjusted growth expectations; unless you think CIBC can push and hold ROE materially above 15% with benign credit, this multiple is rich.

The income statement trend is better than the valuation implies, not better than history. Revenue has compounded from $14.54B in 2021 to $21.16B in 2025, about 9-10% annualized off the raw figures, but net income is only now modestly above the $4.67B earned in 2021 after dipping to $4.52B in 2022 and $3.63B in 2023. In other words, earnings have recovered, not structurally re-rated. If I compare the current market cap of $104.91B to 2025 net income of $6.12B, shareholders are paying a full multiple for what is still plainly a cyclical earnings high-water mark unless proven otherwise. Operating cash flow of $9.83B supports the idea that the franchise is real and cash generative, but for banks OCF is not the valuation anchor that it is for industrials; book value growth and through-cycle ROE are. On that basis, CIBC looks expensive rather than undervalued.

There is also a contradiction in the supplied narrative signals worth calling out. One layer describes the stock as a value play at a P/B discount and leaning on a 4%+ dividend yield, but the actual canonical metrics show 2.44x book and only a 2.54% dividend yield. I would trust the hard metrics over the narrative wrapper. If 2.44x book is the right figure, then the market is assigning CIBC a premium valuation more akin to a high-quality compounder than a plain vanilla mature bank. That makes the bar for execution much higher. With only 0.76% ROA and 13.2% ROE, I do not see evidence of a premium franchise earning profile. The market may be extrapolating the 2024-2025 earnings rebound too aggressively, especially if that rebound was helped by favorable spread dynamics or reserve normalization that do not repeat.

The best case against my view is straightforward: maybe 2023 was the abnormal year, 2025 is the new base, and CIBC deserves to trade above traditional Canadian bank multiples because the business mix and capital generation have improved. Revenue growth of 13.8% year over year and earnings growth of 18.5% are not trivial for a bank this size, and moving from $14.54B of revenue in 2021 to $21.16B in 2025 is materially better than “no growth.” If management can keep net income around or above $6B while compounding book value, then an 18x earnings multiple could compress naturally as earnings catch up. A bull would also argue that a $46.41B equity base against a $104.91B market cap is acceptable if the market believes ROE can inflect higher from 13% toward the mid-teens and stay there. I weigh that less heavily because banks rarely deserve the benefit of the doubt at peak-ish profitability; credit and margin normalization usually show up after investors have already capitalized the good years.

What would change my mind is evidence that this is not just earnings normalization but a real profitability step-up. Specifically, I would want to see another year with net income at or above $6.2B alongside book value growth and ROE sustained above 15%, not just one year at 13.2%. If that happens without the P/B falling, the premium may be earned. Conversely, if earnings slip back toward $5.0B-$5.3B as rates and credit costs normalize, the stock quickly looks mispriced at nearly 18.5x earnings and 2.4x book. For now I think fair value sits meaningfully below the current quote unless the next 12-18 months prove this bank has a higher through-cycle earnings base than its recent history suggests.

Grok Reading
Independent reading · grok-4.5 · generated 2026-08-25 01:46:04
Verdict Recovery fully priced at $114.93 — 18.5x earnings / 2.44x book leaves no margin of safety for a 13% ROE bank facing NIM and provision normalization

The numbers tell a recovery story that has already been paid for. CIBC’s revenue climbed from $14.54B in 2021 to $21.16B in 2025—an 11.8% CAGR—while net income swung from a $3.63B trough in 2023 to $6.12B in 2025, producing a 29.9% earnings CAGR that is almost entirely a two-year bounce off credit and rate stress. Operating cash flow of $9.83B against that $6.12B of net income looks healthy, ROE has settled at 13.2%, and net margin prints an eye-catching 28.9%. None of that is imaginary. What stands out is the multiple attached to it: 18.5x earnings and 2.44x book at $114.93. For a diversified Canadian bank whose ROA is still a thin 0.76% and whose dividend yield is only 2.54%, those are peak-cycle prices on mid-cycle economics. The 2023–25 surge is being capitalized as if it is the new run-rate rather than the unwind of prior provision and NIM pressure.

The internal model conflict is the tell. The valuation composite spits out $136–$150 and an “undervalued” flag, yet simultaneously admits methods disagree and that the market is embedding more growth than the projections support. The thesis layer is clearer and better grounded: a −18 score driven by mechanical margin compression and unavoidable provision normalization, against an oligopoly and wealth-management bid that cannot fully offset a flattening curve and latent commercial/U.S. credit risk. Historical Canadian bank P/Es clustered in the 11–13x zone; 18.5x is a 50%+ premium that only works if the $6.12B earnings base compounds from here without mean-reversion in credit costs. Revenue confidence is high on the trailing print, but the macro tape is labeled headwinds and the market-forces layer correctly flags the recent outperformance as cyclical, not structural.

The strongest case against this read is straightforward: CIBC is still a Big Five oligopoly member with durable deposit funding, a wealth franchise that is gaining share, and a clean-looking balance-sheet snapshot (equity $46.41B, cash $8.92B). If the 13.2% ROE is sustainable and management can keep growing tangible book at mid-to-high single digits while defending the dividend, a 2.4x P/B is defensible under a 9% cost of equity and ~6% growth—exactly the arithmetic that gets you to the composite’s $136 fair value. A bull would also note that the stock has often traded at a discount to Royal and TD, so 18.5x may simply be catch-up rather than froth, and that 13.8% recent revenue growth plus 18.5% earnings growth give the multiple something real to stand on. I weigh that less heavily because the same data show earnings power was $3.63B only two years ago; mean-reversion in provisions does not require a recession, only normalization, and the 2.54% yield offers limited cushion if multiples compress back toward the historical band.

What would flip the view is concrete: two consecutive quarters of stable or expanding net interest margin alongside provisions that stay below the 2024–25 run-rate, or a clear path to ROE sustainably above 15% that would re-justify 2.4x book. Conversely, a 100 bp rise in the credit-loss ratio or a sub-12% ROE print would confirm the multiple is wrong-footed and push fair value toward the low $90s.

Qwen Reading local experiment · off-panel
Independent reading · qwen3.8:27b on the local GPU · generated 2026-08-28 17:11:29 · 83.2s (81 tok/s) · replay of 2026-08-25 panel
Overvalued · conviction 3/5 · bull 4/10
followed the VERDICT/STANCE contract
Verdict Mildly overvalued at $114.93 — 17.1x P/E and 2.26x P/B sit at the upper bound of what 13.2% ROE and the Canadian Big Five 11–13x regime justify; fair value $100–$115, with NIM durability the swing factor.

The number that decides this case is the P/E relative to the Canadian Big Five regime, not the absolute earnings level. CIBC's 2025 net income of $6.12B on $21.16B revenue (28.9% net margin) is a strong print, and the revenue ramp from $14.54B (2021) to $21.16B (2025) — roughly 10% CAGR with the most recent year accelerating to 13.8% YoY — is genuinely above the sector norm. But at $104.91B market cap, the stock trades at 17.1x trailing earnings and 2.26x book ($46.41B equity). The historical P/E range for Canadian Big Five banks, as the briefing's own thesis layer notes, is 11–13x. Even crediting CIBC's above-average 13.2% ROE (NI/equity checks out at $6.12B/$46.41B) and the accelerating revenue, a 14–16x multiple is the upper bound of what I'd pay. At 17x, the market is paying for a growth story that the balance sheet does not yet confirm.

The 2023 earnings dip to $3.63B (down 19.7% from 2022's $4.52B) on a year where revenue actually grew 6.8% is the tell that something non-recurring hit the P&L — elevated provisioning, a restructuring charge, or a specific credit loss. The 2024 rebound to $5.17B and 2025's $6.12B confirm the underlying business is intact. The "earnings CAGR of 29.9%" in the momentum block is an artifact of anchoring to that depressed 2023 base; the true four-year CAGR from 2021's $4.67B is closer to 7%. The "FCF CAGR of 6.7%" and the blank free-cash-flow line are not decision-useful for a bank — operating cash flow of $9.83B is balance-sheet mechanics (deposit flows, loan origination), not a cash-generation metric. The debt-to-equity of zero and blank total-debt line are the same artifact: a bank's liabilities are deposits, not borrowings, and the data source simply does not map them. I set all of these aside.

The prior models disagree with each other and, in different directions, with the raw data. The Valuation Synthesis lands at $136–$150, implying 22–24x 2025 earnings — a multiple I cannot justify for a Canadian bank even with 13.2% ROE. The Thesis Evaluation scores −18 and calls this "peak-cycle multiples" at "20x P/E," which overstates the actual 17.1x and overstates the premium to the 11–13x range (it is 30–55%, not the "50–70%" the thesis claims). The Market Forces "Neutral" call and the "transitory cyclical factors" language are closer to the truth but lack specificity. The Narrative layer's "steady-compounder" framing with "minimal" intensity is the most honest read: this is a dividend-and-capital-return stock, not a growth story, and the 2.54% yield is modest by the group's standards.

The strongest case against my mild overvaluation read is the revenue acceleration. Thirteen-point-eight percent YoY revenue growth in 2025, on top of 9.8% in 2024 and 6.8% in 2023, is not the profile of a mature, margin-compressed bank. If that growth is driven by wealth management fee income and capital markets volume (the bull thesis's "Wealth Management Momentum" at weight 42), it is more durable than NIM-driven growth and supports a higher multiple. A 16x P/E on $6.12B earnings is $104B, or roughly $114 — exactly where the stock sits. So the bull case is: you are not overpaying if the 2025 earnings are the floor, not the peak, and the revenue trend continues. I weigh this seriously, but the 2.26x P/B still requires ROE to hold above 13% for the multiple to be justified, and the "Macro Headwinds" signal in the briefing — flattening yield curves, anemic mortgage growth — is a real threat to NIM that would compress the top line and, with it, the earnings base the multiple sits on.

What would change my mind: a quarterly print showing revenue growth decelerating below 8% YoY while net margin compresses below 25% would confirm the NIM-compression bear case and push fair value toward $95–$100, making the overvaluation more than 10%. Conversely, if the next two quarters show revenue growth holding above 12% with ROE expanding toward 14–15% (implying the 2023 dip was truly one-time and the capital base is working harder), a 16–17x multiple becomes defensible and the stock is fairly valued at current levels. The specific number to watch is the quarterly net interest income line, which the briefing does not break out — without it, I cannot separate NIM-driven growth from fee-driven growth, and that distinction is the entire valuation question.

Experiment only: this reading is not a panel seat and feeds nothing — compare it against the Claude, GPT and Grok readings above.
Big-3 Panel — where each AI stands
Each AI above independently stated a direction (undervalued, fairly valued, or overvalued) and how strongly it believes it (conviction, 0–5). We combine those into a Bull-Bear Index on a 0–10 scale: 5 is neutral, 10 is maximum bullish (undervalued at full conviction), 0 is maximum bearish. We compute the score ourselves with the same arithmetic for every seat — the models never grade their own bullishness — so the three are directly comparable. Δ shows how far each seat sits from the panel average of 1.7; a large Δ marks the dissenting voice, usually the one worth reading.
Claude claude-opus-4-7 2.0
overvalued · conviction 3/5 · Δ +0.3 vs panel · self: 3.0
GPT gpt-5.4 1.0
overvalued · conviction 4/5 · Δ -0.7 vs panel · self: 3.0
Grok grok-4.5 2.0
overvalued · conviction 3/5 · Δ +0.3 vs panel · self: 4.0
Advanced Analysis Forensic deep-dive · separate lenses
Separate reads — Company Quality (is it a great business?), Valuation (is it mispriced?), and General Sentiment (how macro + narrative are pushing it), kept deliberately apart · 2026-08-25 01:53:39
Delvantic - Cairn AI
Quality - wait for a dip near $105 6/10
Solid Big Six bank at a modest ~16% discount to a defensible $136 - fine income compounder, not a fat pitch, and the AI panel's caution about peak-cycle earnings is the tell to wait.
The cruxWhether the $6B net income and improving efficiency are mid-cycle earnings power or a peak that normalizes as PCLs and NIM revert - that single question decides if $115 is a 16% discount or a 15% premium.
Forensic checks Derived mechanically from CM's filed financials — not from the AI lenses
Liquidity & RunwaySelf-Funding
DilutionStable Share Count
Earnings QualityGood Earnings Quality
The four lensesswitch a tab for its full read — score + evidence
Company Quality
+45
Solid
edge √Σ 101 · risk √Σ 52 · conf 7/10

Revenue has compounded from $14.5B (2021) to $21.2B (2025), roughly 9.8% CAGR, with net income recovering from a $3.63B trough in 2023 to $6.12B in 2025 — a clean re-acceleration after the 2023 credit-cycle dip. Operating cash quality is strong: OCF/NI of 1.72x and slightly negative accruals (-0.4% of assets) suggest earnings are backed by cash, not accounting stretch. FCF of $9.83B against a $105B market cap points to a self-funding franchise that does not need capital markets to operate.

Strengths 4
m55
Earnings recovery and growth
Net income rebounded from $3.63B (2023) to $6.12B (2025), with revenue up 45% over five years from $14.5B to $21.2B.
m60
High-quality earnings
OCF/NI at 1.72x and accruals at -0.4% of assets indicate reported profit converts into cash; no accrual buildup flag.
m45
Dilution under control
Diluted share CAGR 1.6%, SBC only 0.1% of revenue — per-share value is not being eroded by issuance.
m40
Substantial FCF generation
$9.83B FCF in 2025 provides ample coverage of dividends and internal capital needs without external funding pressure.
Concerns 3
m35
Altman Z in distress zone
Z-score of 0.16 flags nominal distress, but the model is unreliable for banks whose business model is inherently high leverage — informational, not decisive.
m30
Share count volatility
Diluted shares jumped from 705.8M (2024) to 983.5M (2025) — a ~39% single-year swing that likely reflects a data artifact or preferred conversion; needs verification before trusting the trend.
m25
2023 earnings dip signals cyclicality
Net income fell to $3.63B in 2023 amid credit provisioning cycle — reminder that Canadian bank earnings are exposed to housing and commercial real estate cycles.
This looks like a normal, functioning Big Six Canadian bank coming off a credit-cycle bruise and back in stride — earnings up, cash conversion clean, dilution tame. The Altman Z flag is a false positive for a bank; the model was not built for financials. What I cannot see from this data is the balance-sheet composition that actually matters for a bank: capital ratios, loan book quality, CRE concentration, deposit stability. Absent those, I grade the visible evidence as solid-and-improving, not fortress. The 2025 share-count spike is odd and I want it explained before leaning harder positive.
Verify before trusting this (5)
  • Reconcile the 705.8M (2024) vs 983.5M (2025) diluted share count — is this a restatement, preferred conversion, or data error?
  • CET1 ratio, loan-loss provisions trend, and PCL coverage vs Canadian peers (RBC, TD, BMO)
  • Exposure to Canadian residential mortgages and U.S. commercial real estate (CIBC has historically had higher U.S. office CRE exposure)
  • Net interest margin trajectory and deposit franchise stability
  • Dividend payout ratio and buyback authorization vs regulatory capital constraints
Valuation / Mispricing
+36
Modestly Cheap
edge √Σ 76 · risk √Σ 39 · conf 6/10
price $114.93 vs deserved ~$136, ~16% discount - modestly cheap but not deep value attractive below $105.00

The e2e composite pegs fair value at $136.48 (signal-adjusted $150.26), implying 19-31% upside from $114.93. The anchored-PE method drives this, which is the right lens for a mature bank where earnings power and payout matter more than DCF gymnastics. Earnings quality is good, so no haircut is warranted, and the Solid quality grade supports a deserved multiple in line with Big Six peers rather than a discount. I lean toward the $136 composite over the $150 signal-adjusted number - the latter likely overweights momentum in a rate-sensitive name where NIM direction is uncertain. Against $114.93, roughly $136 deserved gives a ~16-19% margin, which is meaningful but not the kind of gap that screams. Big Six Canadian banks periodically trade at 15-20% discounts to intrinsic value and then close them over 12-24 months as credit fears fade; that appears to be the setup here. The 4%+ yield pays you to wait, and dilution is tame. What is NOT priced in: a benign credit cycle and NIM stabilization. What IS priced in: mortgage stagnation, cost inflation, and lingering credit worry. Fair-value math is not runaway (only ~1.2x price), so I trust the anchor. This is a modest discount to a decent business - worth owning, not worth backing up the truck.

Cheap signals 3
m55
Composite FV $136 vs price $115
Anchored-PE fair value of $136.48 implies ~19% upside; a credible, not runaway, multiple-based estimate for a Big Six bank with clean earnings quality.
m40
Get paid to wait
4%+ dividend yield with tame dilution means holding cost is negative in real terms while the discount closes; typical of Canadian bank re-rating setups.
m35
Bear case largely priced in
NIM compression, mortgage weakness, and credit normalization concerns are well-known and reflected in the ~16% discount to deserved value; not a hidden thesis.
Rich / priced-in 2
m30
Signal-adjusted FV likely optimistic
$150.26 signal-adjusted (31% upside) probably overstates the case in a rate-uncertain environment; I trust the $136 composite more, which trims the margin of safety.
m25
Bank opacity caps deserved multiple
Without visibility into capital ratios, CRE exposure, and loan-book composition, prudence demands not stretching the deserved multiple; caps the upside I will underwrite.
Modestly cheap - I like the ~16% gap to a defensible $136 deserved value, and the dividend pays me while it closes. But this is not a fat pitch. Big Six Canadian banks trade in cycles and I would rather step in harder below $105 where the discount widens to ~23% and the yield pushes toward 5%. At $115 it is a reasonable buy for income-oriented compounding, not a conviction table-pounder. The signal-adjusted $150 FV I largely ignore - too optimistic for a rate-sensitive bank with unknowable balance-sheet detail.
Verify before trusting this (5)
  • CET1 capital ratio and trajectory
  • US commercial real estate exposure and reserve coverage
  • NIM guidance and deposit beta commentary
  • Provision for credit losses trend vs guidance
  • Efficiency ratio and cost discipline updates
General Sentiment
-23
Balanced
tail √Σ 37 · head √Σ 60 · conf 6/10

The market regime is essentially neutral (score +18, VIX under 16, S&P barely off highs), so there is no risk-off wave to punish CM specifically. The narrative around Canadian banks is a low-intensity, durable 'steady compounder' archetype with minimal cult premium - meaning almost no story-driven pressure in either direction. Fundamentals, not sentiment, are setting the price here, which is exactly the setup where sentiment scores near balanced. What tilts it faintly negative is CM's 1.28 beta (unusually high for a diversified bank) combined with a 10y at 4.74% and a flattish curve - the macro overhang for NIM-sensitive lenders is a real, ordinary crosswind even in a calm tape. News flow is benign-to-quiet (a student upskilling poll, a prior AI tool award), and the recent 3% single-day drop was tagged as non-company-specific, consistent with beta drag rather than a narrative crack. Analyst tone is not shouting either way, and the 'discount to intrinsic value' framing is a fundamentals argument, not a sentiment tailwind. Net: a mild headwind from rates/beta, offset by narrative durability and a calm tape - close to balanced.

Tailwinds 2
m30
Durable steady-compounder narrative, low cult
The story is boring, durable, and not running ahead of fundamentals - which means no narrative to crack. In a neutral tape, that absence of story risk is a quiet tailwind for holders.
m22
Calm macro tape, no risk-off pressure
VIX 15.9 and S&P near highs mean there is no broad de-risking wave forcing indiscriminate selling of higher-beta financials. Background conditions are supportive, not punitive.
Headwinds 3
m45
Rate/curve overhang on a NIM-sensitive lender
10y at 4.74% with a nearly flat curve (0.5) is the textbook squeeze for Canadian bank NIMs and mortgage growth. It is an ordinary, persistent crosswind rather than a decisive force, but it lands harder on CM than on defensives.
m35
Elevated beta for a 'defensive' bank
Beta 1.28 means even a neutral-to-slightly-soft tape gets amplified in CM's price - the recent 3% drop with no company-specific cause is exactly that. In any wobble, CM trades worse than its defensive narrative implies.
m20
Sector out of narrative favor
Canadian diversified banks are not part of any active market theme (no AI, no reflation trade catching them); flows and attention sit elsewhere, capping upside from sentiment alone.
I read this as genuinely balanced with a faint negative tilt. There is no active narrative pushing CM around - the story is a low-intensity, durable defensive-bank frame that neither excites nor terrifies, and the tape is neutral enough that no risk-off wave is dragging financials. The real pressure is quiet and structural: a 1.28 beta on a bank whose bull case depends on NIM stability, while the 10y sits at 4.74% with a flat curve. That is an ordinary crosswind, not a decisive force. Sentiment is not the story here - fundamentals and valuation are - which is exactly why the sentiment lens should sit near neutral and let the other two lenses do the work.
Verify before trusting this (4)
  • Any shift in the Canadian yield curve or BoC rhetoric that would change the NIM narrative
  • Credit-loss provisioning trend in the next quarterly print - a crack here would activate the dormant bear story
  • Analyst target revisions post-earnings - divergence from the 'discount to fair value' framing
  • Whether Canadian housing/mortgage data begins to inflect, which could rotate sentiment back into the group
The market-wide tape + this name's exposure to it (beta / sector / narrative durability). Context on the non-fundamental pressure — not a call on the business or the price. processId: detail-general-sentiment
Growth Outlook
+6
Growing
edge √Σ 98 · risk √Σ 93 · conf 7/10

The world is in a Canadian bank sweet spot that is late rather than early: front-end easing has restored a positively sloped curve, deposit costs are repricing down, asset prices have inflated wealth-management fee pools, and capital markets activity is healthy. All three drivers are macro-granted, not company-earned. The structural question underneath is Canadian household leverage: a mortgage stock renewing into materially higher payments caps domestic loan volume growth for years and slowly lifts provisions, which is why the long-run shape for CM is a mid-single-digit compounder with a reliable capital return rather than a growth franchise. Nothing in the technology or competitive landscape threatens the deposit-and-lending core in this window; the Big Six oligopoly and Canadian regulatory perimeter remain the moat that keeps the category's growth from being competed away.

Growth drivers 4
m61
Fee-based engines (wealth + capital markets) outpacing balance-sheet growth
Recent earnings growth (+18.5% YoY) running well ahead of revenue (+13.8%) points to high-margin, capital-light fee revenue — asset management on rising market values, brokerage, underwriting and trading — plus positive operating leverage. These lines scale without proportional risk-weighted asset growth, which is why the earnings CAGR (~30% multi-year) so far exceeds the revenue CAGR (~11.8%).
m51
Deposit repricing and a re-steepened curve support net interest income
Curve at +0.5 with 10y near 4.74 is a positive-slope funding environment for a deposit-funded bank: term deposit and GIC costs reprice down faster than the loan book as the front end falls, mechanically widening margin on a large retail deposit base. Industry-wide net margins are already +4.6pp over three years, confirming this is a category-level margin mechanism rather than a one-bank artifact.
m37
US commercial/private-wealth platform as the incremental growth sleeve
CIBC's cross-border commercial and private wealth franchise grows off a small base into a much larger addressable market than domestic Canada, where mortgage volumes are structurally slow. This is the one segment where CM can add balance sheet at above-Canadian-system growth rates without buying share through price.
m44
Category in confirmed expansion phase
Sector demand score 2, phase expansion, category median recent growth ~12.1%, industry revenue CAGR 8% and earnings CAGR 21.2%. A rising tide means CM does not need to win share to post growth over the next several prints; the cycle itself carries the P&L.
Growth risks 4
m61
Growth rate is not repeatable — decay toward mid-single digits
Low-double-digit revenue and high-teens earnings growth for a mature Canadian bank is a cyclical peak signature (fee tailwinds, benign provisions, margin expansion all firing at once). Normalized Canadian bank earnings power grows roughly with nominal GDP plus modest share gain. The direction of change on the growth rate is more likely down than up from here.
m48
Mortgage renewal reset and rising credit costs
Canadian households carry high leverage and a large tranche of mortgages renews at rates far above origination. That reduces discretionary borrowing capacity (slowing loan growth) and raises provisions simultaneously — a double hit to earnings growth. The -1.00 actual vs -0.40 estimate print signals the P&L is not immune to lumpy charges.
m39
Macro headwind backdrop for the Canadian economy
Brief flags macro headwinds with a high long rate. Canadian growth exposure — trade-sensitive commercial clients, housing, consumer credit — is concentrated and undiversified relative to global peers, so a domestic slowdown compresses volume growth and provisions at the same time.
m32
Fee revenue is markets-dependent, not contracted
The part of the mix growing fastest is the part most exposed to a drawdown: AUM-linked wealth fees and capital markets activity reverse quickly, and would turn a Growing print into Stalling within two quarters without any change in the bank's competitive position.
vs expectations: ~6m above · 1y inline · 2-3y unknown
The forward growth verdict — is the business itself likely to grow (next 2 quarters / year 1 / years 2–3), judged against its category and against printed expectations. The full horizon ladder + creme renders on the Growth Outlook card above. Not a call on the price (Valuation owns that) or the tape (Sentiment owns that).
Please log in to view trade setups
The Augustus trade-setup read is a members feature.
Log in
Lenses kept deliberately separate — Company Quality (price-agnostic), Valuation (price-conditional), General Sentiment (non-fundamental macro/narrative pressure), and Growth Outlook (the forward growth verdict). The scores are not blended. Filing-level items (convertibles, lock-ups, customer concentration) are v2 — see each lens's "verify."
Price Prediction
Higher +10.3% v0.6.0 View full prediction →

When we made this prediction on Aug 25, 2026, CM was $117.66. We expect it to be $129.75 by Feb 2027, and we consider it great value under $105.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 25, 2026.

Price when predicted$117.66
Our estimate for Feb 2027$129.75+10.3%
Great value below$105.00
Price history shown (6 Months)

Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.

Community AI Feedback
No community reviews yet for CM. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
v1.1.760 · f4b58a28 · 2026-10-07 20:07:48